Search
Descriptor in English: Anti-Arrhythmia Agents
Descriptor in Spanish: Antiarrítmicos
Descriptor in Portuguese: Antiarrítmicos
Descriptor in French: Antiarythmiques
Entry term(s): Agents, Anti-Arrhythmia
Agents, Antiarrhythmia
Agents, Antifibrillatory
Anti Arrhythmia Agents
Anti Arrhythmia Drugs
Anti Arrhythmics
Anti-Arrhythmia Drugs
Anti-Arrhythmics
Antiarrhythmia Agents
Antiarrhythmia Drugs
Antiarrhythmic Drugs
Antifibrillatory Agents
Cardiac Depressants
Depressants, Cardiac
Depressants, Myocardial
Drugs, Anti-Arrhythmia
Drugs, Antiarrhythmia
Drugs, Antiarrhythmic
Myocardial Depressants
Tree number(s): D27.505.954.411.097
Scope note: Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade.
Annotation: consider also ARRHYTHMIAS, CARDIAC /drug ther
Allowable Qualifiers: AD administration & dosage
AE adverse effects
AN analysis
BL blood
CF cerebrospinal fluid
CH chemistry
CL classification
CS chemical synthesis
EC economics
HI history
IM immunology
IP isolation & purification
ME metabolism
PD pharmacology
PK pharmacokinetics
PO poisoning
RE radiation effects
SD supply & distribution
ST standards
TO toxicity
TU therapeutic use
UR urine
Online Note: use ANTI-ARRHYTHMIA AGENTS to search MYOCARDIAL DEPRESSANTS 1966-75
History Note: 76; was NON MESH before 1976; MYOCARDIAL DEPRESSANTS was heading 1963-75
See also the descriptors: Adrenergic beta-Antagonists MeSH
Calcium Channel Blockers MeSH
DeCS UI: 902
Descriptor UI: D000889
Date Established: 1976/01/01
Date of Entry: 1975/07/25
Revision Date: 2014/06/25
Anti-Arrhythmia Agents - Preferred
Concept UI M0001326
Scope note Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade.
Preferred term Anti-Arrhythmia Agents
Entry term(s) Agents, Anti-Arrhythmia
Agents, Antiarrhythmia
Anti Arrhythmia Agents
Anti Arrhythmia Drugs
Anti Arrhythmics
Anti-Arrhythmia Drugs
Anti-Arrhythmics
Antiarrhythmia Agents
Antiarrhythmia Drugs
Antiarrhythmic Drugs
Drugs, Anti-Arrhythmia
Drugs, Antiarrhythmia
Drugs, Antiarrhythmic
Cardiac Depressants - Related but not broader or narrower
Concept UI M0001328
Preferred term Cardiac Depressants
Entry term(s) Depressants, Cardiac
Depressants, Myocardial
Myocardial Depressants
Antifibrillatory Agents - Narrower
Concept UI M0001327
Preferred term Antifibrillatory Agents
Entry term(s) Agents, Antifibrillatory



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.


Go to survey